SCHEMBL8016378

SCHEMBL8016378

CC(C)Oc1ccccc1C(C)[C]=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 2/20 0.44
ALDH1A1 P00352 2/20 0.42
ACHE P22303 2/20 0.42
CYP1A2 P05177 1/20 0.37
MAPT P10636 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
KDM4E B2RXH2 2/20 0.36
LMNA P02545 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
CA7 P43166 1/20 0.36
CA9 Q16790 1/20 0.36
ADRA2A P08913 2/20 0.35
ADRA2B P18089 2/20 0.35
ADRA2C P18825 2/20 0.35
NISCH Q9Y2I1 2/20 0.35
GAA P10253 1/20 0.35
TLR8 Q9NR97 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL910886 0.84 CA1 (0.48) ALDH1A1ACHEMAPTKDM4ETDP1
SCHEMBL910554 0.79 ALDH1A1 (0.46) ALDH1A1CYP1A2MAPTCYP2C19KDM4E
SCHEMBL8053594 0.78 IRAK4 (0.48) IRAK4ALDH1A1ACHECYP1A2MAPT
SCHEMBL8245039 0.77 NISCH (0.49) IRAK4ALDH1A1ACHECYP1A2CYP2C9
Formaldehyde SCHEMBL27503267 0.76 IRAK4 (0.47) IRAK4ALDH1A1ACHECYP1A2MAPT
Hydrogen Sulfide SCHEMBL27992927 0.75 NISCH (0.47) IRAK4ALDH1A1ACHECYP1A2CYP2C9
SCHEMBL910855 0.75 L3MBTL1 (0.41) ALDH1A1CYP1A2MAPTCYP2C9CYP2C19
SCHEMBL3210766 0.74 CYP1A2 (0.49) ALDH1A1CYP1A2MAPTCYP2C9CYP2C19
SCHEMBL5966529 0.74 SGMS2 (0.50) ALDH1A1CYP1A2MAPTCYP2C9CYP2C19
SCHEMBL17593428 0.74 IRAK4 (0.44) IRAK4ALDH1A1ACHECYP1A2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0966456-A4 TAXOID REVERSAL AGENTS FOR DRUG-RESISTANCE IN CANCER CHEMOTHERAPY AND PHARMACEUTICAL COMPOSITIONS THEREOF RES FOUNDATION OF (US) 2000-07-26 EP claimed
EP-0966456-A1 TAXOID REVERSAL AGENTS FOR DRUG-RESISTANCE IN CANCER CHEMOTHERAPY AND PHARMACEUTICAL COMPOSITIONS THEREOF THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 1999-12-29 EP claimed
WO-1998030553-A1 TAXOID REVERSAL AGENTS FOR DRUG-RESISTANCE IN CANCER CHEMOTHERAPY AND PHARMACEUTICAL COMPOSITIONS THEREOF THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 1998-07-16 WO claimed
EP-0966456-A4 TAXOID REVERSAL AGENTS FOR DRUG-RESISTANCE IN CANCER CHEMOTHERAPY AND PHARMACEUTICAL COMPOSITIONS THEREOF RES FOUNDATION OF (US) 2000-07-26 EP disclosed
EP-0966456-A1 TAXOID REVERSAL AGENTS FOR DRUG-RESISTANCE IN CANCER CHEMOTHERAPY AND PHARMACEUTICAL COMPOSITIONS THEREOF THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 1999-12-29 EP disclosed
WO-1998030553-A1 TAXOID REVERSAL AGENTS FOR DRUG-RESISTANCE IN CANCER CHEMOTHERAPY AND PHARMACEUTICAL COMPOSITIONS THEREOF THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 1998-07-16 WO disclosed